Onco-cardiology and Cardio-oncology
Prevention of Chemotherapy-induced Cardiotoxicity
Kreg Anderson Workshop
Webinar: November 15, 2013
8:00 a.m.-12:30 p.m.
MD Anderson Cancer Center
Telehealth Videoconference Room, FCT3.5001
Workshop Objectives
To identify opportunities for cardio-protection from perspectives of sarcoma, leukemia, breast cancer, and pediatric patients.
To predict patient’s susceptibility to develop cardiotoxicity before chemotherapy and strategies for PRIMARY PREVENTION.
To discuss strategies for SECONDARY PREVENTION after chemotherapy-induced changes in biomarkers and echo.
To discuss the potential for cessation of heart failure therapy and strategy for long-term follow up.
Registration
Registration for the webinar is free, and we would like to encourage you to view this workshop with your colleagues so you can interact with the speakers as a group.
For information contact Amy Heaton: aheaton@mdanderson.org
Continuing Medical Education (CME)
A physician must individually assess the educational value for each learning experience in which he or she participates to determine if it is appropriate to claim AMA PRA Category 2 Credit™. AMA PRA Category 2 Credit™ is self-claimed, self-directed learning.
Webinar Registration
Registration is required to view the workshop online.
